Aigner, Elmar

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,277

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics

Alcohol Consumption and Health EffectsGenetic Associations and Epidemiology

Cited by 565

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications

Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., et al. (2009) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 421

Cytokine-mediated regulation of iron transport in human monocytic cells

Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 420

Obesity as an emerging risk factor for iron deficiency

Aigner, E., Feldman, A., & Datz, C. (2014) · Nutrients

Iron Metabolism and DisordersTrace Elements in Health

Cited by 328

Pathways underlying iron accumulation in human nonalcoholic fatty liver disease

Aigner, E., Theurl, I., Theurl, M., Lederer, D., Haufe, H., Dietze, O., Strasser, M., Datz, C., & Weiss, G. (2008) · The American Journal of Clinical Nutrition

Iron Metabolism and DisordersLiver Disease Diagnosis and Treatment

Cited by 190

Iron homeostasis in the metabolic syndrome

Datz, C., Felder, T. K., Niederseer, D., & Aigner, E. (2013) · European Journal of Clinical Investigation

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 181

Loss of hepatic Mboat7 leads to liver fibrosis

Thangapandi, V. R., Knittelfelder, O., Brosch, M., Patsenker, E., Vvedenskaya, O., Buch, S., Hinz, S., Hendricks, A., Nati, M., Herrmann, A., et al. (2021) · Gut

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 125

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Traussnigg, S., Schattenberg, J. M., Demir, M., Wiegand, J., Geier, A., Teuber, G., Hofmann, W. P., Kremer, A. E., Spreda, F., Kluwe, J., et al. (2019) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 88

Synovial immunopathology in haemochromatosis arthropathy

Heiland, G. R., Aigner, E., Dallos, T., Sahinbegovic, E., Krenn, V., Thaler, C., Weiss, G., Distler, J. H., Datz, C., Schett, G., et al. (2010) · Annals of the Rheumatic Diseases

Iron Metabolism and DisordersOsteoarthritis Treatment and Mechanisms

Cited by 64

Relationships between education and non-alcoholic fatty liver disease

Koutny, F., Aigner, E., Datz, C., Gensluckner, S., Maieron, A., Mega, A., Iglseder, B., Langthaler, P., Frey, V., Paulweber, B., et al. (2023) · European Journal of Internal Medicine

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 46

VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis

Nell-Duxneuner, V., Axmann, R., Husar-Memmer, E., Dallos, T., Datz, C., Stadlmayr, A., Aigner, E., Englbrecht, M., Schett, G., & Zwerina, J. (2013) · Annals of the Rheumatic Diseases

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 10